Диссертация (1174193), страница 23
Текст из файла (страница 23)
Luoh et al. // J Cell Sci. – 1999. –Vol. 112 ( Pt 23). – P. 4437-48.48.Dunaeva, M. Characterization of the physical interaction of Gli proteins with SUFU proteins /M. Dunaeva, P. Michelson, P. Kogerman et al. // J Biol Chem. – 2003. – Vol. 278. – № 7. – P.5116-22.49.Taylor, M. D. Mutations in SUFU predispose to medulloblastoma / M. D. Taylor, L. Liu, C.Raffel // Nat Genet. – 2002. – Vol.
31. – № 3. – P. 306-10.50.Lee, Y. Loss of suppressor-of-fused function promotes tumorigenesis / Y. Lee, R. Kawagoe, K.Sasai et al. // Oncogene. – 2007. – Vol. 26. – № 44. – P. 6442-7.51.Latini, J. M. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and10Q in morphologically distinct regions of late stage prostate lesions / J. M. Latini, K. M.Rieger-Christ, D.
S. Wang et al. // J Urol. – 2001. – Vol. 166. – № 5. – P. 1931-6.52.Arheden, K. In situ hybridization localizes the human putative oncogene GLI to chromosomesubbands 12q13.3-14.1 / K. Arheden, M. Ronne, N. Mandahl et al. // Hum Genet. – 1989. – Vol.82. – № 1. – P.
1-2.53.Kinzler, K. W. Identification of an amplified, highly expressed gene in a human glioma / K. W.Kinzler, S. H. Bigner, D. D. Bigner et al. // Science. – 1987. – Vol. 236. – № 4797. – P. 70-3.10654.Kinzler, K. W. The GLI gene encodes a nuclear protein which binds specific sequences in thehuman genome / K. W. Kinzler, B. Vogelstein // Mol Cell Biol. – 1990. – Vol. 10. – № 2. – P.634-42.55.Shimokawa, T. Novel human glioma-associated oncogene 1 (GLI1) splice variants revealdistinct mechanisms in the terminal transduction of the hedgehog signal / T. Shimokawa, U.Tostar, M. Lauth et al. // J Biol Chem. – 2008. – Vol. 283.
– № 21. – P. 14345-54.56.Lo, H. W. A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion/ H. W. Lo, H. Zhu, X. Cao et al. // Cancer Res. – 2009. – Vol. 69. – № 17. – P. 6790-8.57.Cao, X. Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factorcontributes to the aggressive behavior of breast cancer cells / X. Cao, J. Geradts, M. W. Dewhirstet al. // Oncogene. – 2012. – Vol. 31. – № 1.
– P. 104-15.58.Katayam, M. Patched and smoothened mRNA expression in human astrocytic tumors inverselycorrelates with histological malignancy / M. Katayam, K. Yoshida, H. Ishimori et al. // JNeurooncol. – 2002. – Vol. 59. – № 2. – P. 107-15.59.Clement, V. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cellself-renewal, and tumorigenicity / V. Clement, P.
Sanchez, N. de Tribolet et al. // Curr Biol. –2007. – Vol. 17. – № 2. – P. 165-72.60.Watkins, D. N. Hedgehog signalling within airway epithelial progenitors and in small-cell lungcancer / D. N. Watkins, D. M. Berman, S. G. Burkholder et al. // Nature. – 2003. – Vol. 422. – №6929. – P. 313-7.61.Kubo, M.
Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer/ M. Kubo, M. Nakamura, A. Tasaki et al. // Cancer Res. – 2004. – Vol. 64. – № 17. – P. 6071-4.62.Sheng, T. Activation of the hedgehog pathway in advanced prostate cancer / T. Sheng, C. Li, X.Zhang et al. // Mol Cancer. – 2004. – Vol.
3. – P. 29.63.Xie, J. Activating Smoothened mutations in sporadic basal-cell carcinoma / J. Xie, M. Murone,S. M. Luoh et al. // Nature. – 1998. – Vol. 391. – № 6662. – P. 90-2.64.Stecca, B. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers / B.Stecca, A. Ruiz i Altaba // EMBO J. – 2009. – Vol.
28. – № 6. – P. 663-76.65.Dennler, S. Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3dependent activation of Gli2 and Gli1 expression in vitro and in vivo / S. Dennler, J. Andre, I.Alexaki et al.
// Cancer Res. – 2007. – Vol. 67. – № 14. – P. 6981-6.66.Cai, Q. Protein kinase Cdelta negatively regulates hedgehog signaling by inhibition of Gli1activity / Q. Cai, J. Li, T. Gao et al. // J Biol Chem. – 2009. – Vol. 284. – № 4. – P. 2150-8.10767.Stecca, B. Melanomas require HEDGEHOG-GLI signaling regulated by interactions betweenGLI1 and the RAS-MEK/AKT pathways / B. Stecca, C. Mas, V. Clement et al. // Proc Natl AcadSci U S A. – 2007. – Vol. 104. – № 14.
– P. 5895-900.68.Ji, Z. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells / Z. Ji,F. C. Mei, J. Xie et al. // J Biol Chem. – 2007. – Vol. 282. – № 19. – P. 14048-55.69.Brechbiel, J. Crosstalk between hedgehog and other signaling pathways as a basis forcombination therapies in cancer / J. Brechbiel, K. Miller-Moslin, A. A. Adjei // Cancer TreatRev. – 2014. – Vol. 40. – № 6. – P.
750-9.70.Li, X. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelialmesenchymal transition in vitro through non-canonical activation of Hedgehog pathway / X. Li,Q. Ma, Q. Xu et al. // Cancer Lett. – 2012. – Vol. 322. – № 2. – P. 169-76.71.Schreck, K. C. The Notch target Hes1 directly modulates Gli1 expression and Hedgehogsignaling: a potential mechanism of therapeutic resistance / K. C.
Schreck, P. Taylor, L.Marchionni et al. // Clin Cancer Res. – 2010. – Vol. 16. – № 24. – P. 6060-70.72.Yoon, J. W. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkittlymphoma / J. W. Yoon, M. Gallant, M. L. Lamm et al. // Mol Cancer Res. – 2013. – Vol. 11. –№ 6. – P. 604-15.73.Beauchamp, E. GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein / E.
Beauchamp,G. Bulut, O. Abaan et al. // J Biol Chem. – 2009. – Vol. 284. – № 14. – P. 9074-82.74.Sheng, T. Regulation of Gli1 localization by the cAMP/protein kinase A signaling axis through asite near the nuclear localization signal / T. Sheng, S. Chi, X. Zhang et al. // J Biol Chem. –2006. – Vol.
281. – № 1. – P. 9-12.75.Wang, B. Evidence for the direct involvement of {beta}TrCP in Gli3 protein processing / B.Wang, Y. Li // Proc Natl Acad Sci U S A. – 2006. – Vol. 103. – № 1. – P. 33-8.76.Huntzicker, E. G. Dual degradation signals control Gli protein stability and tumor formation / E.G. Huntzicker, I. S. Estay, H. Zhen et al. // Genes Dev. – 2006.
– Vol. 20. – № 3. – P. 276-81.77.Di Marcotullio, L. Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itchdependent ubiquitination / L. Di Marcotullio, E. Ferretti, A. Greco et al. // Nat Cell Biol. – 2006.– Vol. 8. – № 12. – P. 1415-23.78.Canettieri, G. Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplayregulates Hedgehog signalling through Gli acetylation / G. Canettieri, L. Di Marcotullio, A.Greco et al. // Nat Cell Biol. – 2010. – Vol. 12. – № 2. – P. 132-42.79.Villavicencio, E.
H. The sonic hedgehog-patched-gli pathway in human development anddisease / E. H. Villavicencio, D. O. Walterhouse, P. M. Iannaccone // Am J Hum Genet. – 2000.– Vol. 67. – № 5. – P. 1047-54.10880.Belloni, E. Identification of Sonic hedgehog as a candidate gene responsible forholoprosencephaly / E. Belloni, M. Muenke, E. Roessler et al. // Nat Genet. – 1996. – Vol. 14.
–№ 3. – P. 353-6.81.Nanni, L. The mutational spectrum of the sonic hedgehog gene in holoprosencephaly: SHHmutations cause a significant proportion of autosomal dominant holoprosencephaly / L. Nanni, J.E. Ming, M. Bocian et al. // Hum Mol Genet. – 1999. – Vol. 8. – № 13. – P. 2479-88.82.Kelley, R. L. Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormalcholesterol metabolism affect the function of Sonic Hedgehog? / R.
L. Kelley, E. Roessler, R. C.Hennekam et al. // Am J Med Genet. – 1996. – Vol. 66. – № 4. – P. 478-84.83.Tint, G. S. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome /G. S. Tint, M. Irons, E. R. Elias et al. // N Engl J Med. – 1994. – Vol. 330. – № 2. – P. 107-13.84.Taylor, M. D. Molecular subgroups of medulloblastoma: the current consensus / M. D. Taylor, P.A. Northcott, A. Korshunov et al.
// Acta Neuropathol. – 2012. – Vol. 123. – № 4. – P. 465-72.85.McGarvey, T. W. PTCH gene mutations in invasive transitional cell carcinoma of the bladder /T. W. McGarvey, Y. Maruta, J. E. Tomaszewski et al. // Oncogene. – 1998. – Vol. 17. – № 9. –P. 1167-72.86.Roberts, W. M. Amplification of the gli gene in childhood sarcomas / W. M. Roberts, E. C.Douglass, S. C. Peiper et al. // Cancer Res.
– 1989. – Vol. 49. – № 19. – P. 5407-13.87.Kalff-Suske, M. Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactylysyndrome / M. Kalff-Suske, A. Wild, J. Topp et al. // Hum Mol Genet. – 1999. – Vol. 8. – № 9. –P. 1769-77.88.Vortkamp, A. GLI3 zinc-finger gene interrupted by translocations in Greig syndrome families /A.
Vortkamp, M. Gessler, K. H. Grzeschik // Nature. – 1991. – Vol. 352. – № 6335. – P. 539-40.89.Mao, X. Molecular and cytogenetic analysis of glioblastoma multiforme / X. Mao, R. A.Hamoudi // Cancer Genet Cytogenet. – 2000. – Vol. 122. – № 2. – P. 87-92.90.Hui, A. B. Detection of multiple gene amplifications in glioblastoma multiforme using arraybased comparative genomic hybridization / A. B. Hui, K. W. Lo, X. L. Yin et al. // Lab Invest. –2001. – Vol. 81.
– № 5. – P. 717-23.91.Wang, K. Gli1 inhibition induces cell-cycle arrest and enhanced apoptosis in brain glioma celllines / K. Wang, L. Pan, X. Che et al. // J Neurooncol. – 2010. – Vol. 98. – № 3. – P. 319-27.92.Wang, K. Sonic Hedgehog/GLI(1) signaling pathway inhibition restricts cell migration andinvasion in human gliomas / K. Wang, L.
Pan, X. Che et al. // Neurol Res. – 2010. – Vol. 32. –№ 9. – P. 975-80.10993.Bar, E. E. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells inglioblastoma / E. E. Bar, A. Chaudhry, A. Lin et al. // Stem Cells. – 2007. – Vol. 25. – № 10. –P. 2524-33.94.Ehtesham, M. Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells /M. Ehtesham, A. Sarangi, J. G. Valadez et al. // Oncogene. – 2007. – Vol. 26. – № 39. – P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
